Literature DB >> 25036565

Collagenous colitis in systemic sclerosis: an overlooked and treatable complication.

Giuseppina Abignano1, Nigel Scott, Frank A Wollheim, Paul Emery, Maya H Buch, Francesco Del Galdo.   

Abstract

Collagenous colitis (CC) is an inflammatory bowel condition of unknown etiology. Systemic sclerosis (SSc) has been associated with CC in a few cases, but it is not clear whether CC could be considered an unusual manifestation of SSc or an independent condition. Here we present a case of SSc-associated CC and compare routine histology and immunofluorescence studies for allograft inflammatory factor 1 and caveolin 1 expression with other cases of CC and healthy controls. All CC biopsies showed characteristic sublaminal collagen accumulation and a decrease of caveolin 1 expression, this latter finding consistent with and common in any fibrotic reaction. In contrast, the expression of allograft inflammatory factor 1 was increased only in the SSc-CC specimen, suggesting a distinct pathogenesis. A literature review revealed 6 previously reported cases of SSc-CC with common clinical features. These observations suggest that CC should be suspected as a rare gastrointestinal complication of SSc and that clinicians should be aware of the possibility in SSc patients developing watery diarrhea.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25036565     DOI: 10.1097/RHU.0000000000000121

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  3 in total

Review 1.  Microscopic colitis in older adults: impact, diagnosis, and management.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  Ther Adv Chronic Dis       Date:  2022-07-05       Impact factor: 4.970

2.  Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis.

Authors:  Gianluca Moroncini; Devis Benfaremo; Alessandra Mandolesi; Armando Gabrielli
Journal:  BMJ Case Rep       Date:  2018-05-18

3.  Microscopic colitis: controversies in clinical symptoms and autoimmune comorbidities.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.